Salinomycin, a potent inhibitor of XOD and URAT1, ameliorates hyperuricemic nephropathy by activating NRF2, modulating the gut microbiota, and promoting SCFA production

Update your browser to view ScienceDirect.

Request details:

Request ID: 8cad2fa80d3c9e74-LAX
IP: 101.37.83.79
UTC time: 2024-09-29T16:00:26+00:00
Browser: Mozilla/5.0 (X11; U; Linux x86_64; en-US; rv:1.9.1.4) Gecko/20091030 Gentoo Firefox/3.5.4